• No se han encontrado resultados

Emerging drugs for autonomic dysfunction in Parkinson's disease

N/A
N/A
Protected

Academic year: 2020

Share "Emerging drugs for autonomic dysfunction in Parkinson's disease"

Copied!
58
0
0

Texto completo

Loading

Figure

Table 1. Efficacy and safety in PD of drugs used for the treatment of autonomic  dysfunction in other population of patients
Table 2. Experimental treatments for autonomic dysfunctions in PD.
Table 3. Empirical recommendations for clinical trials in autonomic dysfunction in  PD

Referencias

Documento similar

We found that (1) vesicular uptake of DA and binding of the VMAT2-selective label [ 3 H]dihydrotetrabenazine were profoundly reduced in PD by 87–90% and 71– 80%, respectively; (2)

word embeddings [32]. BERT-BASED MODELS TO CLASSIFY EEGS 458 To compare the results, we develop two experiments based 459 on BERT models with the same architecture. First, a model

We searched for DNA variants in these miRNA genes in PD-patients, and compared the genotype frequencies between patients and healthy controls... Patients

Objectives: To analyze the relationship between erectile dysfunction and me- tabolic syndrome in a group of Mexican patients, study the influence of other morbidity factors on

Clinical data included Hoehn and Yahr stages, 18 Uni fied Parkinson Disease Rating Scale scores, age at onset of Parkinson ’s disease, duration of disease, presence of tremor or

Los artículos de Revista Médica Electrónica de la Universidad de Ciencias Médicas de Matanzas se comparten bajo los términos de la Licencia Creative Commons Atribución–

Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure..

Although some differences were not significant, the studies included in this systematic review consider that specific trunk exercises or balance training combined with